Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acura Pharmaceuticals has named Robert Jones as the new president and CEO.
Subscribe to our email newsletter
Jones joined Acura in April 2008 as the senior vice president and COO and was reponsible for products development, which use the company’s proprietary abuse deterrent technologies.
Acura’s Oxecta is an immediate-release oxycodone HCl product approved by the FDA in a formulation with features and benefits intended to minimize abuse.
Acura chairman of the board Richard Markham said Bob has the necessary experience to advance the company following the recent FDA approval of Oxecta.